Renaissance Group LLC Merck & Co., Inc. Transaction History

Renaissance Group LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$70.31 - $77.77 $241,022 - $266,595	-3,428 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$68.86 - $81.11 $18.6 Million - $21.9 Million	-269,860 Reduced 98.75%	3,428 $264,000
Q4 2020 Feb 12, 2021	SELL	$71.77 - $79.65 $1.57 Million - $1.74 Million	-21,812 Reduced 7.39%	273,288 $22.4 Million
Q3 2020 Nov 12, 2020	BUY	$73.18 - $82.95 $1.54 Million - $1.74 Million	20,982 Added 7.65%	295,100 $24.5 Million
Q2 2020 Aug 12, 2020	SELL	$70.42 - $80.13 $1.24 Million - $1.41 Million	-17,608 Reduced 6.04%	274,118 $21.2 Million
Q1 2020 May 06, 2020	SELL	$63.36 - $87.82 $626,693 - $868,627	-9,891 Reduced 3.28%	291,726 $22.4 Million
Q4 2019 Feb 12, 2020	BUY	$77.58 - $87.54 $23.4 Million - $26.4 Million	301,617 New	301,617 $27.4 Million

3,824

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $261B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Renaissance Group LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Group LLC with notifications on news.